Annual Net Margin
-179.87%
+129.71%+41.90%
31 December 2023
Summary:
Esperion Therapeutics annual net profit margin is currently -179.87%, with the most recent change of +129.71% (+41.90%) on 31 December 2023. During the last 3 years, it has fallen by -116.78% (-185.10%). ESPR annual net margin is now -185.10% below its all-time high of -63.09%, reached on 31 December 2020.ESPR Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
-57.18%
+26.69%+31.82%
30 September 2024
Summary:
Esperion Therapeutics quarterly net profit margin is currently -57.18%, with the most recent change of +26.69% (+31.82%) on 30 September 2024. Over the past year, it has increased by +64.25% (+52.91%). ESPR quarterly net margin is now -195.16% below its all-time high of 60.09%, reached on 31 March 2019.ESPR Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.9% | +52.9% |
| 3 y3 years | -185.1% | +88.1% |
| 5 y5 years | - | +99.2% |
ESPR Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -185.1% | +47.6% | -229.1% | +88.1% |
| 5 y | 5 years | -185.1% | +47.6% | -197.4% | +99.2% |
| alltime | all time | -185.1% | +100.0% | -195.2% | +99.2% |
Esperion Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -57.18%(-31.8%) |
| June 2024 | - | -83.87%(-289.3%) |
| Mar 2024 | - | 44.30%(-125.4%) |
| Dec 2023 | -179.87%(-41.9%) | -174.71%(+43.9%) |
| Sept 2023 | - | -121.43%(-37.3%) |
| June 2023 | - | -193.65%(-23.7%) |
| Mar 2023 | - | -253.68%(-14.0%) |
| Dec 2022 | -309.58%(-9.8%) | -294.86%(+1.5%) |
| Sept 2022 | - | -290.40%(-17.5%) |
| June 2022 | - | -352.02%(+16.9%) |
| Mar 2022 | - | -301.18%(-28.8%) |
| Dec 2021 | -343.04% | -422.82%(-12.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -481.55%(+348.4%) |
| June 2021 | - | -107.40%(-90.6%) |
| Mar 2021 | - | -1139.82%(+5.1%) |
| Dec 2020 | -63.09%(-3.7%) | -1084.00%(-51.4%) |
| Sept 2020 | - | -2228.99%(-3896.6%) |
| June 2020 | - | 58.71%(-101.4%) |
| Mar 2020 | - | -4252.66%(-32.6%) |
| Dec 2019 | -65.49%(-100.0%) | -6308.15%(-9.5%) |
| Sept 2019 | - | -6970.13%(+26.2%) |
| June 2019 | - | -5521.49%(-9288.7%) |
| Mar 2019 | - | 60.09% |
| Dec 2000 | -1.38 M%(+29.2%) | - |
| Dec 1999 | -1.07 M% | - |
FAQ
- What is Esperion Therapeutics annual net profit margin?
- What is the all time high annual net margin for Esperion Therapeutics?
- What is Esperion Therapeutics annual net margin year-on-year change?
- What is Esperion Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly net margin year-on-year change?
What is Esperion Therapeutics annual net profit margin?
The current annual net margin of ESPR is -179.87%
What is the all time high annual net margin for Esperion Therapeutics?
Esperion Therapeutics all-time high annual net profit margin is -63.09%
What is Esperion Therapeutics annual net margin year-on-year change?
Over the past year, ESPR annual net profit margin has changed by +129.71% (+41.90%)
What is Esperion Therapeutics quarterly net profit margin?
The current quarterly net margin of ESPR is -57.18%
What is the all time high quarterly net margin for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly net profit margin is 60.09%
What is Esperion Therapeutics quarterly net margin year-on-year change?
Over the past year, ESPR quarterly net profit margin has changed by +64.25% (+52.91%)